Entera Bio Ltd.

ENTX

$2.95

+1.03%

N/A+$0.03

Healthcare

Biotechnology

NASDAQ

Active Trading

Entera Bio Ltd. is a biopharmaceutical firm in the clinical development phase, dedicated to creating and marketing oral medications composed of large ...

Financial Highlights of ENTX

Profitability trend

Latest / TTM · 6 periods

Gross Margin

0.0%

Net Margin

0.0%

P/E Ratio

-8.82x

n/a

Debt / Equity

0.06

n/a

Current Ratio

8.98

Dividend Yield

0.0%

Understanding

TTM —

Interest coverage is weak

Financial highlights

Latest / TTM · 6 periods

Snapshot

Latest / TTM: 2026-09-04

Gross Margin

0.0%

Net Margin

0.0%

P/E Ratio

-8.82x

Debt / Equity

0.06

Profitability

Profitability table

Metric	2021	2022	2023	2024	2025	2026
Gross MarginGross profit as a percentage of revenue.	34.7%	-23.1%	0.0%	5.0%	0.0%	—
Operating MarginOperating income as a percentage of revenue.	-2139.6%	-9752.2%	0.0%	-5295.6%	-27450.0%	—
Net MarginNet income as a percentage of revenue.	-2134.3%	-9754.5%	0.0%	-5271.3%	-27235.7%	—
EBITDA MarginEBITDA divided by revenue.	-2130.3%	-9604.5%	0.0%	-5238.1%	-27164.3%	—
Pre-tax MarginPre-tax profit as a percentage of revenue.	-2144.7%	-9652.2%	0.0%	-5263.5%	-27235.7%	—

Liquidity & leverage

Liquidity & leverage table

Metric	2021	2022	2023	2024	2025	2026
Current RatioCurrent assets divided by current liabilities.	8.01	9.58	10.32	7.63	3.23	—
Quick RatioLiquid assets divided by current liabilities.	8.01	9.58	10.32	7.63	3.23	—
Cash RatioCash and equivalents divided by current liabilities.	7.87	9.18	10.10	7.36	3.23	—
Debt / AssetsDebt as a share of total assets.	1.2%	0.7%	3.3%	2.9%	3.1%	—
Debt / EquityDebt compared with shareholder equity.	0.01	0.01	0.04	0.03	0.04	—

Operating efficiency

Operating efficiency table

Metric	2021	2022	2023	2024	2025	2026
Receivables TurnoverHow often receivables are collected in a year.	3.12x	0.54x	0.00x	1.44x	0.19x	—
Inventory TurnoverHow often inventory is sold in a year.	0.00x	0.00x	0.00x	0.00x	0.00x	—
Payables TurnoverHow often payables are paid in a year.	2.25x	9.71x	0.67x	1.30x	0.09x	—
Asset TurnoverRevenue generated per dollar of assets.	0.02x	0.01x	0.00x	0.02x	0.00x	—
Working Capital TurnoverRevenue generated per dollar of working capital.	0.04x	0.01x	0.00x	0.02x	0.01x	—

Valuation ratios

Valuation ratios table

Metric	2021	2022	2023	2024	2025	2026
P/E RatioPrice paid for each dollar of earnings.	-6.00x	-1.62x	-1.94x	-8.48x	-7.76x	—
P/B RatioPrice paid for each dollar of book value.	3.27x	1.79x	1.68x	9.88x	6.84x	—
P/S RatioPrice paid for each dollar of sales.	129.07x	156.94x	0.00x	440.99x	2133.59x	—
P/FCF RatioPrice paid for each dollar of free cash flow.	-8.12x	-1.68x	-2.38x	-11.70x	-11.98x	—
Dividend YieldAnnual dividend divided by current share price.	0.0%	0.0%	0.0%	0.0%	0.0%	—

About UsPrivacy PolicyTerms of ServiceDisclaimerStock DirectoryETFsIndices13F HoldingsAnalyst TargetsFree ToolsTechnology MapJoin our Slack

Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer